The COVID-19 pandemic has created many challenges across the healthcare system. The greatest impact to transfusion medicine has been the ability to maintain a healthy blood supply across the nation and an imbalance between the supply of blood components and the demand to meet patient needs. The recent and ongoing severe blood shortage has led to the need make difficult decisions as to who should receive blood and who should wait. Beyond the potential for these difficult decisions within each hospital or region, the shortage has impacted the United States and the world unequally raising many ethical questions about how blood should be allocated fairly. An ethical framework is needed to guide these decisions. Speakers will share their perspectives on how should blood be allocated both within hospitals and across nations and how to prioritize patients most in need of blood components during critical blood shortages. Attendees will learn how to create ethical frameworks to guide decision making as well as generate proactive solutions including the development of futility protocols.
All relevant financial relationships have been mitigated.
Describe the current ethical challenges created by the ongoing critical blood shortage.
Discuss potential proactive solutions including development of futility protocols to guide transfusion decision making.
Create an ethical framework to understand how to triage patient transfusion needs.
Suzanne Arinsburg, DO:
Nothing to Disclose
Pampee Young, MD, PhD:
Fresenius Kabi: Consultant
Ortho Diagnostics: Speaker's Bureau
Eluciderm: Board of Directors
Lauren Smith, MD:
Bayer: Expert witness
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM22-03-O: (On-Demand) Ethical Considerations in Blood Supply Management During Critical Blood Shortages (Enduring) Evaluation